Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $802.13 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2024) |
| Amgen Inc. | $120.00 | 1 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $115.56 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $112.44 | 1 | $0 (2021) |
| ABBVIE INC. | $106.06 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $100.00 | 1 | $0 (2021) |
| Lilly USA, LLC | $37.83 | 2 | $0 (2022) |
| Paratek Pharmaceuticals, Inc. | $28.00 | 2 | $0 (2021) |
| Heron Therapeutics, Inc. | $24.44 | 1 | $0 (2021) |
| Novo Nordisk Inc | $20.39 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.06 | 3 | Phathom Pharmaceuticals, Inc. ($125.00) |
| 2022 | $153.39 | 3 | Biohaven Pharmaceutical Holding Company Ltd. ($115.56) |
| 2021 | $297.68 | 7 | Janssen Pharmaceuticals, Inc ($112.44) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Bone Health | ||||||
| 01/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $106.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 05/10/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $115.56 | General |
| Category: PRIMARY CARE | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $112.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2021 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Not Applicable | ||||||
| 10/06/2021 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Postoperative Pain | ||||||
| 09/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PRIMARY CARE | ||||||
| 06/28/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: ANTIBIOTIC | ||||||
| 05/03/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ANTIBIOTIC | ||||||
| 03/09/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 441 | 535 | $86,631 | $23,707 |
| 2022 | 4 | 97 | 121 | $14,311 | $5,221 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 157 | $30,776 | $8,771 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 109 | 109 | $31,844 | $7,368 | 23.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 58 | 62 | $4,030 | $2,146 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $8,512 | $2,067 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $5,491 | $1,661 | 30.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 34 | 74 | $2,220 | $1,200 | 54.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 30 | $2,010 | $233.25 | 11.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 37 | 39 | $702.00 | $132.99 | 18.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 11 | 14 | $686.00 | $82.32 | 12.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 12 | 12 | $360.00 | $43.45 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 37 | $7,252 | $2,499 | 34.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 25 | $1,625 | $1,030 | 63.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,054 | $946.08 | 23.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 23 | 46 | $1,380 | $746.12 | 54.1% |
About Armando Contreras, ARNP
Armando Contreras, ARNP is a Adult Health healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376567701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Armando Contreras, ARNP has received a total of $802.13 in payments from pharmaceutical and medical device companies, with $351.06 received in 2024. These payments were reported across 13 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($802.13).
As a Medicare-enrolled provider, Contreras has provided services to 538 Medicare beneficiaries, totaling 656 services with total Medicare billing of $28,927. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Melbourne, FL
- Active Since 07/27/2006
- Last Updated 02/14/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1376567701
Products in Payments
- NURTEC ODT (Drug) $215.56
- VOQUEZNA (Drug) $125.00
- EVENITY (Biological) $120.00
- XARELTO (Drug) $112.44
- UBRELVY (Drug) $106.06
- NUZYRA (Drug) $28.00
- Zynrelef (Drug) $24.44
- Ozempic (Drug) $20.39
- TALTZ (Drug) $19.22
- TRULICITY (Drug) $18.61
- GELSYN-3 (Device) $12.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Melbourne
Ms. Melissa Studebaker, Arnp-C, ARNP-C
Adult Health — Payments: $13,705
Cynthia Furlan, Aprn, APRN
Adult Health — Payments: $7,791
Melissa Frank, Arnp, ARNP
Adult Health — Payments: $7,554
Felmer Stewart, Aprn, APRN
Adult Health — Payments: $6,342
Doris Thornhill, Aprn, APRN
Adult Health — Payments: $5,877
Guilene Davilmar, Arnp, ARNP
Adult Health — Payments: $4,679